[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"baseline-thrombocytopenia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:baseline-thrombocytopenia":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100533268","dual-antiplatelet-therapy-dapt-in-patients-with-baseline-thrombocytopenia-100533268",false,"NCT06223607","Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia","Inclusion Criteria:\n\n* ≥ 18 years\n* PCI with either DES or BMS during study time period (April 1, 2018 through July 1 2021)\n* Thrombocytopenia defined as platelet count \\\u003C100 x103 \u002FµL on at least one occasion prior to PCI\n* At least one dose of DAPT post-PCI with aspirin and either clopidogrel or ticagrelor\n\nExclusion Criteria:\n\n* Death within 48 hours post-PCI\n* DAPT prior to cardiac catheterization","ALL","18 Years",{"count":18,"type":19},300,"ESTIMATED","OBSERVATIONAL","The use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).",[23],"Baseline Thrombocytopenia","RECRUITING","2026-06-08",{"date":27,"type":28},"2026-06-10","ACTUAL",{"date":30,"type":28},"2022-08-22",{"date":32,"type":19},"2027-12-22",{"name":34,"class":35},"Methodist Health System","OTHER"]